Please login to the form below

We must encourage conversations around clinical trials in minority groups

We recently set out to gain a deeper understanding on how COVID-19 has affected ethnic minorities, including their perspective on the pandemic, clinical trials, and general healthcare.

Lack of diversity and inclusion within clinical trials is not a recent issue, and many people have been fighting long and hard, including ourselves, to put strategies in place to improve the representation of minority groups in clinical research. However, the COVID-19 pandemic has brought the issue to the forefront, increasing awareness around the lack of diversity and why it is so important for us to address the issue and make a change.

So, at COUCH Health, via Demand Diversity, we recently set out to gain a deeper understanding on how COVID-19 has affected ethnic minorities, including their perspective on the pandemic, clinical trials, and general healthcare.

Overall, 411 people took part in the research, including the following ethnicities:

  • White
  • Black/African/Caribbean/Black British
  • Asian/Asian British
  • Middle Eastern
  • Mixed/Multiple ethnic groups.

73.1% of the participants were female, 25.4% were male, and 1.2% preferred not to say. 7 people took part in the interviews, all of whom were female from different ethnic backgrounds, including those from Indian, Black African, Indo Caribbean, Pakistani, and Hispanic backgrounds.

Healthcare can be a taboo subject for some

During the interviews, one prominent theme that stood out was the topic of conversations considered to be taboo. Based on the participants’ responses, it appears that ethnic minority groups don’t actively speak about their own healthcare, as it can be very personal:

"I think healthcare needs cultural competency. For example, in the South Asian community, older women do not know how to explain mental health problems. They complain about back pain, stomach pain, but they are describing anxiety or depression. But unless you know the questions to ask people, this doesn’t come out. For some cultures, psychological symptoms are alien words.”-  British Asian, female

“Death is a taboo word – no one talks about it. No one wants to admit that they have an illness because it is linked to death and people do not want to become untouchable. So anybody whose got it is like gossip. My experience in the NHS, if anyone was close to death, it is not an acceptable thing because they always believe that god will make it alright."- British Asian, female

“In African communities, if people pass away from cancer, they don’t mention it, it’s very secretive. I think it’s just a taboo in our society and people don’t like to be associated with those types of things. In the white community they are very honest but, in our community, they don’t like to share those personal details." - Black African, female

These responses suggest that healthcare either isn’t communicated properly (such as psychological symptoms being seen as “alien words”) or the topic of healthcare in general is avoided in certain ethnic groups. But why? What is the reason behind this lack of communication?

The reasons behind the lack of healthcare conversations

It’s important for us to understand why these conversations are being avoided.

  • Pride: One participant’s response suggested that they may be avoiding conversations due to their pride, for example not wanting to be seen as inferior – “nobody wants to admit they have an illness”.
  • Fear of stigma: One participant’s response highlighted that there’s a lot of gossip in communities, and another suggested that they “don’t like to be associated with those types of things” and therefore, don’t like to share personal details.

This lack of communication could be a potential explanation as to why certain communities are less likely to take part in clinical trials. And it’s time for us to think about what we can do to improve this.

Let’s make a change: What can we do to encourage conversations and clinical trial participation?

Speaking up about healthcare is important for many reasons, regardless of ethnicity. Of course, our health in general should be spoken about, but awareness around clinical trials specifically needs to be improved, too – such as giving people reassurance that clinical trials are conducted for beneficial reasons. This can be done through community engagement, building trust and relationships, and talking about it to raise awareness.

We believe that from our research, in order to break the stigma, thought leaders within these communities must speak up to normalise these conversations. Ways we could do this include:

Using a trusted source

Many of the people we interviewed believe visiting community centres and places of worship is the most successful way to try and change negative perceptions of clinical trials. Advertising on Asian TV shows was also deemed as the best way to connect with this community, as people will trust information showed on there.

Improving community engagement and rebuilding trust

With behaviours so deeply rooted into their culture, it’s going to take a lot of work to make a change and improve diversity. Mistrust is a huge barrier for some and is something that will need to be rebuilt to reassure communities and raise awareness of the benefits of clinical trials. It’s about building relationships within a community and encouraging the ‘information to trickle in’. It’s not something that can be combatted with a ‘one-off campaign’.

Considering cultural safety

One participant responded with: “Maybe the people who run the clinical trials need to speak different languages and become more culturally competent and find ways of communicating more.” It seems that cultural safety could be one way of improving relationships and understanding around healthcare and clinical trials. And as a result, could encourage more people to talk and more people to consider taking part in clinical trials

Time to make a change

There’s no doubt that we have a long way to go to improve diversity in clinical trials. However, the insights we have gained from our research have helped us to understand that the topic of healthcare and clinical trials is often seen as a taboo subject in ethnic minority groups, and it’s our responsibility to help make a change.

It is clear that we need to help break the stigma, rebuild trust, and raise awareness of the benefits of clinical trials to ensure diversity is improved.

You can access the full research report here.

2nd February 2021

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?
COUCH Health
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history.
COUCH Health
#DemandDiversity: The science behind diversity
We’re going back to the basics to explain why it’s so important for us to make a change.
COUCH Health
5 reasons clinical trial drop-out rates are on the rise
According to a recent report by the CSDD, patient recruitment rates have been steadily increasing, which is great news! The study found that 77% of clinical trials are now either meeting or exceeding their enrolment targets, in comparison to just 47% in 2012.
COUCH Health
#DemandDiversity: Names erased from history: A dive into black history of clinical research
You might be aware that February is Black History Month in the United States. So, we wanted to take the time to highlight some monumental moments and figures in the black history of clinical trials and medical research and share these with you
COUCH Health
How media portrayal of clinical trials can lead to underrepresentation
We knew that ethnic minority communities were being disproportionately affected by COVID-19, and we also knew that ethnic minorities were underrepresented in COVID-19 clinical trials. What we don’t know, however, is why ethnic minority groups weren’t taking part. So, we decided to do some digging.
COUCH Health